Vertex Pharmaceuticals Inc / Ma

E. Ohman J:or Asset Management AB VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/12/2026

Shares

9,023

Value ($000)

4,091

Weight

0.1%

2006 Q4 - 2025 Q4 (66 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/12/2026	4,091	0.1%	9,023	12/31/2025
2025 Q3	10/17/2025	4,120	0.1%	10,520	9/30/2025
2025 Q2	7/8/2025	4,684	0.1%	10,520	6/30/2025
2025 Q1	4/11/2025	5,571	0.1%	11,490	3/31/2025
2024 Q4	1/27/2025	4,728	0.1%	11,740	12/31/2024
2024 Q3	10/23/2024	4,795	0.1%	10,310	9/30/2024
2024 Q2	8/13/2024	5,184	0.1%	11,060	6/30/2024
2024 Q1	5/14/2024	4,389	0.1%	10,500	3/31/2024
2023 Q4	2/15/2024	4,069	0.1%	10,000	12/31/2023
2023 Q3	2/6/2024	4,138	0.2%	11,900	9/30/2023
2022 Q2	4/5/2024	3,128	0.1%	11,100	6/30/2022
2022 Q1	4/5/2024	2,949	0.1%	11,300	3/31/2022
2021 Q4	4/5/2024	2,811	0.1%	12,800	12/31/2021
2021 Q3	4/5/2024	2,159	0.1%	11,900	9/30/2021
2021 Q2	4/5/2024	2,399	0.1%	11,900	6/30/2021
2021 Q1	4/5/2024	37,402	1.4%	174,050	3/31/2021
2020 Q4	4/5/2024	2,552	0.1%	10,800	12/31/2020
2020 Q3	4/5/2024	2,939	0.1%	10,800	9/30/2020
2020 Q2	4/5/2024	2,903	0.2%	10,000	6/30/2020
2020 Q1	4/5/2024	2,118	0.2%	8,900	3/31/2020
2019 Q4	4/5/2024	2,693	0.1%	12,300	12/31/2019
2018 Q1	4/5/2024	962	0.1%	5,900	3/31/2018
2017 Q4	4/5/2024	974	0.1%	6,500	12/31/2017
2017 Q3	4/5/2024	988	0.1%	6,500	9/30/2017
2017 Q2	4/5/2024	812	0.1%	6,300	6/30/2017
2017 Q1	4/5/2024	689	0.1%	6,300	3/31/2017
2016 Q4	4/5/2024	405	0.1%	5,500	12/31/2016
2016 Q3	4/5/2024	480	0.1%	5,500	9/30/2016
2016 Q2	4/5/2024	361	0.1%	4,200	6/30/2016
2016 Q1	4/5/2024	334	0.1%	4,200	3/31/2016
2015 Q4	4/5/2024	654	0.1%	5,200	12/31/2015
2015 Q3	4/5/2024	542	0.1%	5,200	9/30/2015
2015 Q2	4/5/2024	642	0.2%	5,200	6/30/2015
2015 Q1	4/5/2024	613	0.1%	5,200	3/31/2015
2014 Q4	4/5/2024	620	0.1%	5,200	12/31/2014
2014 Q3	4/5/2024	584	0.1%	5,200	9/30/2014
2014 Q2	4/5/2024	492	0.1%	5,200	6/30/2014
2014 Q1	4/5/2024	368	0.1%	5,200	3/31/2014
2013 Q4	4/5/2024	384	0.1%	5,200	12/31/2013
2013 Q3	4/5/2024	394	0.1%	5,200	9/30/2013
2013 Q2	4/5/2024	416	0.1%	5,200	6/30/2013
2013 Q1	4/5/2024	379	0.1%	6,900	3/31/2013
2012 Q4	4/5/2024	193	0.1%	4,600	12/31/2012
2012 Q3	4/5/2024	257	0.1%	4,600	9/30/2012
2012 Q2	4/5/2024	257	0.1%	4,600	6/30/2012
2012 Q1	4/5/2024	189	0.1%	4,600	3/31/2012
2011 Q4	4/5/2024	153	0.1%	4,600	12/31/2011
2011 Q3	4/5/2024	205	0.1%	4,600	9/30/2011
2011 Q2	4/5/2024	239	0.1%	4,600	6/30/2011
2011 Q1	4/5/2024	219	0.1%	4,600	3/31/2011
2010 Q4	4/5/2024	161	0.1%	4,600	12/31/2010
2010 Q3	4/5/2024	159	0.1%	4,600	9/30/2010
2010 Q2	4/5/2024	151	0.1%	4,600	6/30/2010
2010 Q1	4/5/2024	102	0.1%	2,500	3/31/2010
2009 Q4	4/5/2024	107	0.1%	2,500	12/31/2009
2009 Q3	4/5/2024	136	0.1%	3,600	9/30/2009
2009 Q2	4/5/2024	128	0.1%	3,600	6/30/2009
2008 Q4	4/5/2024	55	0.1%	1,800	12/31/2008
2008 Q3	4/5/2024	60	0.1%	1,800	9/30/2008
2008 Q2	4/5/2024	60	0.0%	1,800	6/30/2008
2008 Q1	4/5/2024	43	0.0%	1,800	3/31/2008
2007 Q4	4/5/2024	42	0.0%	1,800	12/31/2007
2007 Q3	4/5/2024	69	0.1%	1,800	9/30/2007
2007 Q2	4/5/2024	51	0.0%	1,800	6/30/2007
2007 Q1	4/5/2024	50	0.0%	1,800	3/31/2007
2006 Q4	4/5/2024	67	0.1%	1,800	12/31/2006